Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Beckmann

Showing results (851-860 of 1,041) with videos related to

Pageof 105
Sort By:
Oncotarget|October 15, 2017
Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome lociDylan M Glubb, Sharon E Johnatty, Michael C J Quinn, et al.
British Journal of Cancer|July 8, 2015
Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association ConsortiumC M Nagle, S C Dixon, A Jensen, et al.
British Journal of Cancer|October 29, 2014
Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium studyM Köbel, J Madore, S J Ramus, et al.
Cancer Research|April 12, 2015
Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density MeasuresJennifer Stone, Deborah J Thompson, Isabel Dos Santos Silva, et al.
Geburtshilfe Und Frauenheilkunde|October 27, 2018
Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Nummer 032/034-OL, April 2018) - Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial CancerGünter Emons, Eric Steiner, Dirk Vordermark, et al.
Geburtshilfe Und Frauenheilkunde|August 17, 2023
Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022). Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer, Geriatric Assessment and Supply StructuresGünter Emons, Eric Steiner, Dirk Vordermark, et al.
Geburtshilfe Und Frauenheilkunde|December 25, 2018
Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Number 032/034-OL, April 2018) - Part 2 with Recommendations on the Therapy and Follow-up of Endometrial Cancer, Palliative Care, Psycho-oncological/Psychosocial Care/Rehabilitation/Patient Information and Healthcare FacilitiesGünter Emons, Eric Steiner, Dirk Vordermark, et al.
Journal of the National Cancer Institute|January 23, 2023
Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysisZhuxuan Fu, Maria Mori Brooks, Sarah Irvin, et al.
Geburtshilfe Und Frauenheilkunde|September 19, 2024
Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022) - Part 2 with Recommendations on the Therapy of Precancerous Lesions and Early-stage Endometrial Cancer, Surgical Therapy, Radiotherapy and Drug-based Therapy, Follow-up Care, Recurrence and Metastases, Psycho-oncological Care, Palliative Care, Patient Education, and Rehabilitative and Physiotherapeutic CareGünter Emons, Eric Steiner, Dirk Vordermark, et al.
Oncotarget|February 4, 2016
Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancerJuliet D French, Sharon E Johnatty, Yi Lu, et al.
Pageof 105

Showing results (851-860 of 1,041) with videos related to

Sort By:
Pageof 105
Oncotarget|October 15, 2017
Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome lociDylan M Glubb, Sharon E Johnatty, Michael C J Quinn, et al.
British Journal of Cancer|July 8, 2015
Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association ConsortiumC M Nagle, S C Dixon, A Jensen, et al.
British Journal of Cancer|October 29, 2014
Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium studyM Köbel, J Madore, S J Ramus, et al.
Cancer Research|April 12, 2015
Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density MeasuresJennifer Stone, Deborah J Thompson, Isabel Dos Santos Silva, et al.
Geburtshilfe Und Frauenheilkunde|October 27, 2018
Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Nummer 032/034-OL, April 2018) - Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial CancerGünter Emons, Eric Steiner, Dirk Vordermark, et al.
Geburtshilfe Und Frauenheilkunde|August 17, 2023
Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022). Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer, Geriatric Assessment and Supply StructuresGünter Emons, Eric Steiner, Dirk Vordermark, et al.
Geburtshilfe Und Frauenheilkunde|December 25, 2018
Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Number 032/034-OL, April 2018) - Part 2 with Recommendations on the Therapy and Follow-up of Endometrial Cancer, Palliative Care, Psycho-oncological/Psychosocial Care/Rehabilitation/Patient Information and Healthcare FacilitiesGünter Emons, Eric Steiner, Dirk Vordermark, et al.
Journal of the National Cancer Institute|January 23, 2023
Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysisZhuxuan Fu, Maria Mori Brooks, Sarah Irvin, et al.
Geburtshilfe Und Frauenheilkunde|September 19, 2024
Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022) - Part 2 with Recommendations on the Therapy of Precancerous Lesions and Early-stage Endometrial Cancer, Surgical Therapy, Radiotherapy and Drug-based Therapy, Follow-up Care, Recurrence and Metastases, Psycho-oncological Care, Palliative Care, Patient Education, and Rehabilitative and Physiotherapeutic CareGünter Emons, Eric Steiner, Dirk Vordermark, et al.
Oncotarget|February 4, 2016
Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancerJuliet D French, Sharon E Johnatty, Yi Lu, et al.
Pageof 105